Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT01015664 · TERMINATED
Trial details
- NCT number
- NCT01015664
- Sponsor
- University of Tennessee Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.